Stay updated on MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.

Latest updates to the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Taiwan study site address changed from Taoyuan District, Taiwan, 333 to Taoyuan, Taiwan, 333, updating the city designation in the location listing.SummaryDifference0.0%

- Check20 days agoChange DetectedThe page’s footer revision/version label has been updated from **v3.5.2** to **v3.5.3**, indicating a site release or documentation version change rather than a change to the study content.SummaryDifference0.0%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check55 days agoChange DetectedRevision: v3.5.0 is now shown, replacing v3.4.3. No study content or navigation changes are evident.SummaryDifference0.0%

- Check70 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no changes to study data, criteria, or listed locations are evident.SummaryDifference0.0%

Stay in the know with updates to MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MEDI4736 and Tremelimumab in Gastric Cancer Clinical Trial page.